Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia

P. S. George, R. J. McCrimmon (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
164 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences